Cargando…
Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity
Drug-induced liver injury (DILI) is an important problem both in the clinic and in the development of new safer medicines. Two pivotal adaptation and survival responses to adverse drug reactions are oxidative stress and cytokine signaling based on the activation of the transcription factors Nrf2 and...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830895/ https://www.ncbi.nlm.nih.gov/pubmed/26026609 http://dx.doi.org/10.1007/s00204-015-1536-3 |
_version_ | 1782426970242416640 |
---|---|
author | Herpers, Bram Wink, Steven Fredriksson, Lisa Di, Zi Hendriks, Giel Vrieling, Harry de Bont, Hans van de Water, Bob |
author_facet | Herpers, Bram Wink, Steven Fredriksson, Lisa Di, Zi Hendriks, Giel Vrieling, Harry de Bont, Hans van de Water, Bob |
author_sort | Herpers, Bram |
collection | PubMed |
description | Drug-induced liver injury (DILI) is an important problem both in the clinic and in the development of new safer medicines. Two pivotal adaptation and survival responses to adverse drug reactions are oxidative stress and cytokine signaling based on the activation of the transcription factors Nrf2 and NF-κB, respectively. Here, we systematically investigated Nrf2 and NF-κB signaling upon DILI-related drug exposure. Transcriptomics analyses of 90 DILI compounds in primary human hepatocytes revealed that a strong Nrf2 activation is associated with a suppression of endogenous NF-κB activity. These responses were translated into quantitative high-content live-cell imaging of induction of a selective Nrf2 target, GFP-tagged Srxn1, and the altered nuclear translocation dynamics of a subunit of NF-κB, GFP-tagged p65, upon TNFR signaling induced by TNFα using HepG2 cells. Strong activation of GFP-Srxn1 expression by DILI compounds typically correlated with suppression of NF-κB nuclear translocation, yet reversely, activation of NF-κB by TNFα did not affect the Nrf2 response. DILI compounds that provided strong Nrf2 activation, including diclofenac, carbamazepine and ketoconazole, sensitized toward TNFα-mediated cytotoxicity. This was related to an adaptive primary protective response of Nrf2, since loss of Nrf2 enhanced this cytotoxic synergy with TNFα, while KEAP1 downregulation was cytoprotective. These data indicate that both Nrf2 and NF-κB signaling may be pivotal in the regulation of DILI. We propose that the NF-κB-inhibiting effects that coincide with a strong Nrf2 stress response likely sensitize liver cells to pro-apoptotic signaling cascades induced by intrinsic cytotoxic pro-inflammatory cytokines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-015-1536-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4830895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-48308952016-04-25 Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity Herpers, Bram Wink, Steven Fredriksson, Lisa Di, Zi Hendriks, Giel Vrieling, Harry de Bont, Hans van de Water, Bob Arch Toxicol Organ Toxicity and Mechanisms Drug-induced liver injury (DILI) is an important problem both in the clinic and in the development of new safer medicines. Two pivotal adaptation and survival responses to adverse drug reactions are oxidative stress and cytokine signaling based on the activation of the transcription factors Nrf2 and NF-κB, respectively. Here, we systematically investigated Nrf2 and NF-κB signaling upon DILI-related drug exposure. Transcriptomics analyses of 90 DILI compounds in primary human hepatocytes revealed that a strong Nrf2 activation is associated with a suppression of endogenous NF-κB activity. These responses were translated into quantitative high-content live-cell imaging of induction of a selective Nrf2 target, GFP-tagged Srxn1, and the altered nuclear translocation dynamics of a subunit of NF-κB, GFP-tagged p65, upon TNFR signaling induced by TNFα using HepG2 cells. Strong activation of GFP-Srxn1 expression by DILI compounds typically correlated with suppression of NF-κB nuclear translocation, yet reversely, activation of NF-κB by TNFα did not affect the Nrf2 response. DILI compounds that provided strong Nrf2 activation, including diclofenac, carbamazepine and ketoconazole, sensitized toward TNFα-mediated cytotoxicity. This was related to an adaptive primary protective response of Nrf2, since loss of Nrf2 enhanced this cytotoxic synergy with TNFα, while KEAP1 downregulation was cytoprotective. These data indicate that both Nrf2 and NF-κB signaling may be pivotal in the regulation of DILI. We propose that the NF-κB-inhibiting effects that coincide with a strong Nrf2 stress response likely sensitize liver cells to pro-apoptotic signaling cascades induced by intrinsic cytotoxic pro-inflammatory cytokines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-015-1536-3) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2015-05-31 2016 /pmc/articles/PMC4830895/ /pubmed/26026609 http://dx.doi.org/10.1007/s00204-015-1536-3 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Organ Toxicity and Mechanisms Herpers, Bram Wink, Steven Fredriksson, Lisa Di, Zi Hendriks, Giel Vrieling, Harry de Bont, Hans van de Water, Bob Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity |
title | Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity |
title_full | Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity |
title_fullStr | Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity |
title_full_unstemmed | Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity |
title_short | Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity |
title_sort | activation of the nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of nf-κb activation and sensitizes toward tnfα-induced cytotoxicity |
topic | Organ Toxicity and Mechanisms |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830895/ https://www.ncbi.nlm.nih.gov/pubmed/26026609 http://dx.doi.org/10.1007/s00204-015-1536-3 |
work_keys_str_mv | AT herpersbram activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity AT winksteven activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity AT fredrikssonlisa activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity AT dizi activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity AT hendriksgiel activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity AT vrielingharry activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity AT debonthans activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity AT vandewaterbob activationofthenrf2responsebyintrinsichepatotoxicdrugscorrelateswithsuppressionofnfkbactivationandsensitizestowardtnfainducedcytotoxicity |